Enfusion stock exits NYSE after Clearwater completes acquisition

Enfusion stock is no longer listed on the NYSE as of September 24, 2026, after Clearwater Analytics completed its acquisition of the investment management software company. The transaction gives investors a clear reference point: USD 11.25 per share and a stated deal value of USD 1.5 billion.

Clearwater deal ended ENFN trading

MarketMinute reports that Clearwater completed the Enfusion acquisition on April 21, 2025, in a transaction valued at USD 1.5 billion. The same record identifies Enfusion as Enfusion, Inc. and its former ticker as ENFN.

The acquisition announcement dated January 13, 2025, set the purchase price at USD 11.25 per share. Clearwater also agreed to pay USD 30 million to terminate Enfusion's tax receivable agreement, with the merger consideration delivered through an equal mix of cash and stock.

Deal value versus operating base

Multiples.vc lists USD 198 million of last-twelve-month revenue for January 2025 and an acquisition value of USD 1.5 billion. Its comparison places the transaction at 7.4x EV to revenue and 83.9x EV to EBITDA.

That comparison matters because Enfusion was not valued like a conventional listed stock after the transaction. The company moved from an NYSE-listed software business to an acquired platform inside Clearwater, so the relevant benchmark is the merger consideration rather than a live ENFN quote.

Enfusion's market status

Multiples.vc describes Enfusion as a Chicago-headquartered provider of portfolio management, risk analytics, and middle-office software for asset managers. The page states that Enfusion supported over 800 investment firms managing USD 1.2 trillion in assets, while its platform reported 99.99 percent uptime.

For investors reviewing historical ENFN data, the key dates are January 13, 2025, when the deal was announced, and April 21, 2025, when Clearwater announced completion. The USD 11.25 per share consideration and the USD 1.5 billion transaction value define the final public-market reference for Enfusion stock.